REGISTERED NUMBER: 12170218 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST AUGUST 2025

FOR

WU MEDICAL LIMITED

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Dr F Wu

REGISTERED OFFICE:

c/o Michael Heaven & Associates Limited

47 Calthorpe Road

Edgbaston

BIRMINGHAM

West Midlands

B15 1TH

REGISTERED NUMBER:

12170218 (England and Wales)

ACCOUNTANTS:

Michael Heaven & Associates Limited

Chartered Certified Accountants

47 Calthorpe Road

Edgbaston

BIRMINGHAM

B15 1TH

BANKERS:

Santander UK PLC

Bridle Road

Bootle

Merseyside

L30 4GB

INCORPORATED:

22nd August 2019

FIXED ASSETS

Tangible assets

4

22,661

29,910

Investments

5

494,475

100,000

517,136

129,910

CURRENT ASSETS

Debtors

7,656

11,849

Cash at bank

3,228

251,337

10,884

263,186

CREDITORS

Amounts falling due within one year

37,891

41,961

NET CURRENT (LIABILITIES)/ASSETS

(27,007

)

221,225

TOTAL ASSETS LESS CURRENT LIABILITIES

490,129

351,135

PROVISIONS FOR LIABILITIES

6

15,776

7,927

NET ASSETS

474,353

343,208

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

474,253

343,108

SHAREHOLDERS' FUNDS

474,353

343,208

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st August 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31st August 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17th December 2025 and were signed by:

Dr F Wu - Director

1.	STATUTORY INFORMATION

Wu Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover represents the value of services provided to the extent that there is a right to consideration and is recorded at the value of the consideration due.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life:

Computer equipment - 25% straight line

Motor vehicles - 25% reducing balance

Fixtures and Fittings - 25% reducing balance

Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable and loans from related parties.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors

Short term debtors are measured at transaction price, less any impairment.

Creditors

Short term trade creditors are measured at the transaction price.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1st September 2024

59,578

Additions

1,828

Disposals

(882

)

At 31st August 2025

60,524

DEPRECIATION

At 1st September 2024

29,668

Charge for year

8,195

At 31st August 2025

37,863

NET BOOK VALUE

At 31st August 2025

22,661

At 31st August 2024

29,910

5.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST OR VALUATION

At 1st September 2024

100,000

Additions

457,614

Disposals

(98,567

)

Revaluations

35,428

At 31st August 2025

494,475

NET BOOK VALUE

At 31st August 2025

494,475

At 31st August 2024

100,000

Cost or valuation at 31st August 2025 is represented by:

Totals

£

Valuation in 2025

36,444

Cost

458,031

494,475

6.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

15,776

7,927

Deferred

tax

£

Balance at 1st September 2024

7,927

Provided during the year

7,849

Balance at 31st August 2025

15,776

Provisions are recognised when the company has a legal or constructive obligation at the reporting date

as a result of a past event, it is probable that the company will be required to settle the obligation and the

amount of the obligation can be reliably estimated. Provisions are recognised at the best estimate of the

amount required to settle the obligation at the reporting date.

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

100

100

8.	RELATED PARTY DISCLOSURES

At the year end the amount due to the director totalled £79. The loan is interest free and repayable on demand.